I advise public companies - from Fortune 500 to small cap biopharmaceutical companies - on a variety of corporate governance matters including environmental & social (ESG) issues and proxy voting/solicitation. I am a frequent speaker/panelist on corporate governance topics and my practice focuses on governance advisory work, including reviewing clients’ current practices and preparing them for shareholder engagement.
August 25–27, 2026 · Live on SuperCrowd.tv, syndicated via the e360tv Network · SuperCrowd26 has wrapped
Explore SuperCrowd26Impact crowdfunding stories, live shows and deals from the SuperCrowd — free.
Your note is on its way to Devin. If you left an email, Devin can reply.